AMC CLINICAL TRIAL - EVALUATION OF DKA AND INSULIN ADMINISTRATION
Comparison of constant rate intravenous infusion and intermittent intramuscular administration of regular insulin in cats with diabetic ketoacidosis
Purpose
Diabetes is a common problem in cats, and can progress to diabetic ketosis/ketoacidosis (DKA). DKA is a severe illness which often requires intensive in-hospital insulin treatment. Multiple routes of insulin administration have been described in cats with DKA; in this study, researchers will identify whether insulin administered intravenously or intramuscularly is most effective to treat these cats.
Eligibility
To be eligible for this study, cats must meet several criteria, including (but not limited to) the following:
Clinical signs of diabetic ketosis/ketoacidosis (lethargy, weight loss, vomiting, appetite loss)
Blood glucose >250 mg/dL and positive serum ketones
For more information about this study and to inquire about eligibility and potential study benefits, please contact Dr. Melissa Clark (melissa.clark@amcny.org) or Dr. Elizabeth Appleman (elizabeth.appleman@amcny.org). You may also call the Internal Medicine-A Service at 212-329-8734